Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) ...

NeoGenomics launched the NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling test, expanding the company’s ...

The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various ...

Upgrades to software on Bionano’s Stratys™ Compute, a server that leverages advanced GPU chips, double the number of cancer samples that can be analyzed per week and expand functionality to include ...

Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling. Comprehensive ...

In this video interview, Michael Miller, chief operating officer at Quanterix, outlines key technical and regulatory ...

Discover how AVA brings scale and reproducibility to organ‑chip technology, enabling human‑relevant insights that accelerate ...

Highly sensitive and efficient analysis with an emphasis on specific regions of the genome. epicGEN NGS panels are designed ...

Women with PCOS and thrombotic disease face a higher risk of vascular events like stroke and heart attack at younger ages, ...

The single-tier test uses artificial intelligence to accurately detect Lyme disease from the first few weeks of infection ...

Melbourne-headquartered Trajan’s capital equipment segment is at the forefront of laboratory automation and analytical ...

It will also have the capability to provide information on the response to certain treatments The test will be easy to use, ...